Growth factor receptor-bound protein 7 (GRB7), which is a signal transducing adaptor protein that is overexpressed in ovarian cancer, promotes constitutive activation of the MAPK/ERK pathway and thereby leads to enhanced FOXM1 activity [205]. This evidence concerns the gene GRB7 and ovarian cancer.